A pilot study on improvements in attention function in major depressive disorder after 12 weeks of escitalopram monotherapy or combined treatment with agomelatine

OBJECTIVE: This study aimed to explore both impairments in attention function in patients with major depressive disorder (MDD) and the efficacy of escitalopram monotherapy or combination therapy with agomelatine. METHODS: A total of 54 patients with MDD and 46 healthy controls (HCs) were included. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhe, Wu, Ting-Ting, Xiong, Yi-Ting, Zhang, Xin-Yang, Bao, Yan-Ping, Guo, Li-Bo, Han, Bao-Jie, Li, Su-Xia, Wang, Yu-Feng, Lu, Lin, Wang, Xue-Qin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325661/
https://www.ncbi.nlm.nih.gov/pubmed/37426111
http://dx.doi.org/10.3389/fpsyt.2023.1188175

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10325661/
https://www.ncbi.nlm.nih.gov/pubmed/37426111
http://dx.doi.org/10.3389/fpsyt.2023.1188175

Ejemplares similares